Diagnostic Blood Testing

Full-service hospital laboratory offering comprehensive blood testing from routine haematology and biochemistry to advanced cardiac, hormonal, metabolic, and cancer marker panels, with same-day results for most tests.

Mount Elizabeth Hospitals' integrated clinical laboratory provides a comprehensive diagnostic blood testing service for outpatients, inpatients, and medical tourists seeking thorough health assessment. As a hospital-grade laboratory operating under JCI accreditation, the facility processes specimens with stringent quality controls and reports results with clinical reference ranges calibrated for the Southeast Asian population. Routine testing includes full blood count (FBC/CBC) with differential, comprehensive metabolic panel covering liver function tests (LFT), renal function tests (RFT), electrolytes, fasting glucose and HbA1c, lipid profile with total cholesterol, LDL, HDL and triglycerides, and thyroid function tests (TSH, free T3, free T4). These panels underpin annual health screening and are essential baseline investigations before starting medications or undergoing surgery. Cardiac biomarker testing includes high-sensitivity troponin, BNP and NT-proBNP for heart failure assessment, and CRP for inflammation. Advanced cardiovascular risk panels incorporating apolipoprotein B, Lp(a), homocysteine, and omega-3 index are available for patients seeking deeper cardiovascular risk stratification beyond standard lipids. Hormone testing covers the full reproductive and endocrine axis: testosterone (free and total), oestradiol, FSH, LH, SHBG, DHEA-S, prolactin, cortisol, ACTH, IGF-1, and insulin — relevant for patients investigating fertility, menopause, andropause, adrenal function, and growth hormone status. Thyroid antibody panels (anti-TPO, anti-TG) complete the thyroid evaluation for autoimmune thyroid disease. Cancer marker panels include PSA (total and free) for prostate, CA-125 for ovarian, CA 19-9 for pancreatic and biliary, CEA for colorectal, AFP for liver and testicular, and CA 15-3 for breast cancer monitoring. These are used in conjunction with imaging for staging and treatment response monitoring rather than as standalone screening in asymptomatic individuals. Vitamin and micronutrient testing (Vitamin D, B12, folate, iron studies, zinc, magnesium) and inflammatory markers (ESR, CRP, ferritin) complete the extensive menu. Results for routine panels are typically available within four to six hours, with urgent STAT results returned within one to two hours.